RecallDepth
Class II Terminated

Cyclobenzaprine Hydrochloride Tablets, 7.5mg, 100 count tablets per bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc. Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-3330-01

Company
Teva Pharmaceuticals Usa
Recall Initiated
July 29, 2021
Posted
September 8, 2021
Recall Number
D-0774-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
9,655 bottles
Firm Location
Parsippany, NJ, United States

Reason for Recall

CGMP Deviations: Out of specification (OOS) test result for Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC) for an excipient batch of Dibasic Calcium Phosphate.

Distribution

Product was distributed nationwide.

Lot / Code Info

1408821A, exp. date 08/2023 (labeler - Teva)

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls